Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
作者信息
Ghany Marc G, King Wendy C, Hinerman Amanda S, Lok Anna S F, Lisker-Melman Mauricio, Chung Raymond T, Terrault Norah, Janssen Harry L A, Khalili Mandana, Lee William M, Lau Daryl T Y, Cloherty Gavin A, Sterling Richard K
机构信息
Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA.
Graduate School of Public Health University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
出版信息
Hepatology. 2024 Nov 1;80(5):E82-E84. doi: 10.1097/HEP.0000000000000963. Epub 2024 Jun 11.
Abstract
摘要
相似文献
1
Reply: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
Hepatology. 2024 Nov 1;80(5):E82-E84. doi: 10.1097/HEP.0000000000000963. Epub 2024 Jun 11.
2
Predictive role of early treatment dynamics of HBV RNA and HBcrAg for HBeAg seroconversion in children with chronic hepatitis B.
J Med Virol. 2024 May;96(5):e29670. doi: 10.1002/jmv.29670.
3
Use of HBV RNA and to predict change in serological status and disease activity in CHB.
Hepatology. 2023 Nov 1;78(5):1542-1557. doi: 10.1097/HEP.0000000000000413. Epub 2023 Apr 20.
4
Letter to the Editor: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
Hepatology. 2024 Nov 1;80(5):E81. doi: 10.1097/HEP.0000000000000960. Epub 2024 Jun 14.
5
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.
Rev Med Virol. 2022 Nov;32(6):e2353. doi: 10.1002/rmv.2353. Epub 2022 Apr 20.
6
Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion.
J Clin Microbiol. 2025 Sep 10;63(9):e0038525. doi: 10.1128/jcm.00385-25. Epub 2025 Aug 19.
7
Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients.
Chin Med J (Engl). 2021 Mar 17;134(10):1160-1167. doi: 10.1097/CM9.0000000000001418.
8
[Dynamic changes of HBsAb and its predictive value in patients with chronic hepatitis B receiving antiviral therapy for clinical cure].
Zhonghua Gan Zang Bing Za Zhi. 2025 Jun 20;33(6):551-559. doi: 10.3760/cma.j.cn501113-20250506-00173.
9
Differential Intrahepatic Integrated HBV DNA Patterns Between HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B.
medRxiv. 2025 Mar 4:2025.02.28.25322668. doi: 10.1101/2025.02.28.25322668.
10
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.
J Hepatol. 2025 Jun 21. doi: 10.1016/j.jhep.2025.06.012.
引用本文的文献
1
A potential age-independent MASLD-related liver fibrosis index based on metabolic profiling.
Sci Rep. 2025 Sep 2;15(1):32328. doi: 10.1038/s41598-025-18172-x.
2
Racial Differences in Liver Fibrosis Burden.
Dig Dis Sci. 2025 Mar 18. doi: 10.1007/s10620-025-08936-w.
3
Association of liver fibrosis with aneurysm size and mortality risk in patients undergoing open abdominal aortic aneurysm repair.
Sci Rep. 2025 Jan 26;15(1):3301. doi: 10.1038/s41598-025-88133-x.
4
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review.
J Gastroenterol. 2025 Jan;60(1):10-23. doi: 10.1007/s00535-024-02179-8. Epub 2024 Dec 9.
本文引用的文献
1
Letter to the Editor: The exact predictive value of HBcrAg and HBV RNA in serological status and disease activity in CHB.
Hepatology. 2024 Nov 1;80(5):E81. doi: 10.1097/HEP.0000000000000960. Epub 2024 Jun 14.
2
Use of HBV RNA and to predict change in serological status and disease activity in CHB.
Hepatology. 2023 Nov 1;78(5):1542-1557. doi: 10.1097/HEP.0000000000000413. Epub 2023 Apr 20.
Zotero 插件